These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 17973940)

  • 21. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.
    Räz B; Janner M; Petkovic V; Lochmatter D; Eblé A; Dattani MT; Hindmarsh PC; Flück CE; Mullis PE
    J Clin Endocrinol Metab; 2008 Mar; 93(3):974-80. PubMed ID: 18029459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.
    Audí L; Esteban C; Carrascosa A; Espadero R; Pérez-Arroyo A; Arjona R; Clemente M; Wollmann H; Fryklund L; Parodi LA;
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5038-43. PubMed ID: 17003087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.
    Hartleb S; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Pfützner A; Kann PH; ;
    Pharmacogenomics; 2011 Dec; 12(12):1653-61. PubMed ID: 22026923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP.
    Glad CA; Johannsson G; Carlsson LM; Svensson PA
    Growth Horm IGF Res; 2010 Jun; 20(3):270-3. PubMed ID: 20219401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
    Adetunji OR; MacFarlane IA; Javadpour M; Alfirevic A; Pirmohamed M; Blair JC
    Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of fl/d3 polymorphism of growth hormone receptor with the first- and second-year response to recombinant human growth hormone therapy in pre-pubertal Greek children with idiopathic isolated growth hormone deficiency.
    Vassiliou G; Rousso I; Katzos G; Vavatsi-Christaki N; Tzimagiorgis G
    J Endocrinol Invest; 2011 Sep; 34(8):609-14. PubMed ID: 20855935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
    Morin A; Guimarey L; Apezteguia M; Santucci Z
    Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Leu544Ile polymorphism of the growth hormone receptor gene affects the serum cholesterol levels during GH treatment in children with GH deficiency.
    Ihara K; Inuo M; Kuromaru R; Miyako K; Kohno H; Kinukawa N; Hara T
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):212-7. PubMed ID: 17547682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences.
    Bannink EM; van der Palen RL; Mulder PG; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):343-9. PubMed ID: 19506392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
    Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
    Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A; Guimarey L; Santucci Z; Apezteguia M
    Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome.
    Park SW; Lee ST; Sohn YB; Kim SH; Cho SY; Ko AR; Ji ST; Kwon JY; Yeau S; Paik KH; Kim JW; Jin DK
    Am J Med Genet A; 2011 Dec; 155A(12):2970-3. PubMed ID: 22052808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor.
    Blum WF; Machinis K; Shavrikova EP; Keller A; Stobbe H; Pfaeffle RW; Amselem S
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult height in Turner Syndrome girls after long-term growth hormone treatment.
    Morin A; Guimarey LM; Apezteguia M; Santucci ZC
    Medicina (B Aires); 2009; 69(4):431-6. PubMed ID: 19770097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
    Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.